Ketoconazole, an antiglucocorticoid drug, was administered to 10
hypercortisolemic depressed patients for up to 6 weeks. Three patients
dropped out because of side effects or intercurrent illness. The remaining
seven had significant ketoconazole-associated decreases in serum cortisol
levels and in depression ratings. Antiglucocorticoid agents may be useful
probes for investigating the sequelae of hypercortisolemia in patients with
major depression.
Abstract Teaser